Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year … -
JA Cauley, L Norton, ME Lippman, S Eckert, KA … - Breast Cancer Research and Treatment, 2001 - Springer
... Report Continued breast cancer risk reduction in postmenopausal women treated with
raloxifene: 4-year results from the MORE trial ... Breast cancer ascertainment ...
… for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project … -
B Fisher - J Natl Cancer I, 1998 - jnci.oxfordjournals.org
... ARTICLES. Tamoxifen for Prevention of Breast Cancer: Report of the National
Surgical Adjuvant Breast and Bowel Project P-1 Study. ...
The Nottingham prognostic index in primary breast cancer -
MH Galea, RW Blamey, CE Elston, IO Ellis - Breast Cancer Research and Treatment, 1992 - Springer
Page 1. Breast Cancer Research and Treatment 22: 207-219, 1992. ? 1992 Kluwer Academic
Publishers. ... The Nottingham Prognostic Index in primary breast cancer ...
… between EGF receptor family members: a new signaling paradigm with implications for breast cancer … -
HS Earp, TL Dawson, X Li, H Yu - Breast Cancer Research and Treatment, 1995 - Springer
Page 1. Breast Cancer Research and Treatment 35:115-132, 1995. ... Overexpression of
either protein in advanced breast cancer correlates with poor prognosis. ...
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu … -
DJ Slamon, GM Clark, SG Wong, WJ Levin, A Ullrich, … - Science, 1987 - sciencemag.org
... Science articles. Human breast cancer: correlation of relapse and survival
with amplification of the HER-2/neu oncogene. DJ Slamon ...
Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association … -
M Toi, K Inada, H Suzuki, T Tominaga - Breast Cancer Research and Treatment, 1995 - Springer
Page 1. Breast Cancer Research and Treatment 36: 193-204, 1995. ... Key words: angiogenesis,
microvessel density, vascular endothelial growth factor, breast cancer ...
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. -
AE Giuliano, DM Kirgan, JM Guenther, DL Morton - Annals of Surgery, 1994 - pubmedcentral.nih.gov
... Copyright notice. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. ...
Controversies in primary breast cancer management. Am J Surg. ...
… plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2 -
DJ Slamon, B Leyland-Jones, S Shak, H Fuchs, V … - New England Journal of Medicine, 2001 - content.nejm.org
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast
Cancer That Overexpresses HER2. ... Adjuvant trastuzumab for breast cancer. ...
Breast cancer survivors: Psychosocial concerns and quality of life -
PA Ganz, A Coscarelli, C Fred, B Kahn, ML Polinsky … - Breast Cancer Research and Treatment, 1996 - Springer
Breast Cancer Research and Treatment 38: 183-199, 1996. ? 1996 Kluwer Academic
Publishers. ... Breast cancer survivors: psychosocial concerns and quality of life ...
Gene expression profiling predicts clinical outcome of breast cancer -
LJ van't Veer, H Dai, MJ van de Vijver, YD He, AAM … - Nature, 2002 - Mass Med Soc
... Gene "Fingerprint" Improves Prognostic Accuracy in Breast Cancer. ... van 't Veer LJ
et al. Gene expression profiling predicts clinical outcome of breast cancer. ...
Source: Google Scholar |